Dudediligence.

Biogen Inc

BIIBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$905,414

4 notices · 4,594 sh

Oct 2025 to Oct 2026

Reported ·

$665,664

2 sales · 1 buy · $585 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 2 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-04: Minor Lloyd, Form 1442026-08-03: Minor Lloyd, Form 1442026-02-09: Singhal Priya, Form 1442026-02-02: Singhal Priya, Form 1442026-02-02: Singhal Priya, sold2026-02-09: Singhal Priya, sold2026-02-12: Murphy Nicole, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-04Minor Lloyd, Director$119,169
593 shplan 2026-05-04Form 4s on file end Jun 23144 ↗
2026-08-03Minor Lloyd, Director$120,581
593 shplan 2026-05-04Form 4s on file end Jun 23144 ↗
2026-02-09Singhal Priya, Head of Development$531,548
2,660 shplan 2025-02-18144 ↗
Form 4, 2026-02-10: sold 2,660 at $199.83 Form 4 ↗
2026-02-02Singhal Priya, Head of Development$134,116
748 shplan 2025-02-18144 ↗
Form 4, 2026-02-03: sold 748 at $179.30 Form 4 ↗